<?xml version="1.0" encoding="UTF-8"?>
<p class="p">Zhao 
 <italic class="italic">et al</italic>. evaluated the effect of 
 <italic class="italic">OD</italic> tablet (ODT) in type two diabetes mellitus (DM) patients in a four-week clinical trial. Their results showed that ODT could improve the glycometabolism of DM patients sufficiently and also reduce the impairment of renal function in diabetic neuropathy [
 <xref rid="b83-2093-6966-v22-n03-016" ref-type="bibr" class="xref">83</xref>].
</p>
